SCHEMBL6775138

SCHEMBL6775138

COC(=O)c1ccc([N+](=O)[O-])cc1-c1cccc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.48
POLB P06746 3/20 0.47
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
MAPT P10636 5/20 0.47
NPC1 O15118 3/20 0.47
LMNA P02545 3/20 0.47
RAB9A P51151 2/20 0.47
RORC P51449 1/20 0.47
TNF P01375 1/20 0.47
NOD1 Q9Y239 1/20 0.47
PTGES O14684 1/20 0.46
EIF4A1 P60842 1/20 0.46
HPGD P15428 1/20 0.46
DUSP3 P51452 1/20 0.46
PTPN5 P54829 1/20 0.46
PTPN11 Q06124 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 2/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8365466 0.84 EIF4A1 (0.57) ALOX5POLBMEN1KMT2AMAPT
SCHEMBL6775231 0.83 RORC (0.46) POLBMEN1KMT2ANPC1LMNA
SCHEMBL14812007 0.82 MAPT (0.49) POLBMEN1KMT2AMAPTNPC1
SCHEMBL30338973 0.80 PTGDR2 (0.54) POLBMEN1KMT2AMAPTLMNA
SCHEMBL5935194 0.80 PTGDR2 (0.54) POLBMEN1KMT2AMAPTLMNA
SCHEMBL8365504 0.80 SLC6A3 (0.65) POLBMEN1KMT2AMAPTNPC1
SCHEMBL10010690 0.79 SLC6A3 (0.58) POLBMEN1KMT2AMAPTNPC1
SCHEMBL6775688 0.79 SLC6A3 (0.49) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL18302008 0.79 SLC6A3 (0.54) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL9042674 0.78 MEN1 (0.48) ALOX5POLBMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693123-B2 (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA UNIVERSITY OF PITTSBURGH 2004-02-17 US disclosed
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed
EP-0794789-A4 INHIBITORS OF PRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-05-26 EP disclosed
EP-0794789-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-09-17 EP disclosed
WO-1996021456-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1996-07-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 ALOX5 608/4885POLB 2803/4885MEN1 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.